Elizabeth Rubin, DO

Jonathan Weltz, D.O., is a board-certified hematologic oncologist at Eugene M. & Christine E. Lynn Cancer Institute and is fluent in English and conversational Hebrew.Prior to joining Lynn Cancer Institute, Dr. Weltz completed a clinical fellowship in hematology-oncology at New York University Langone Long Island School of Medicine.Dr. Weltz earned his osteopathic medicine degree from New York Institute of Technology College of Osteopathic Medicine and completed his internal medicine residency at Maimonides Medical Center in Brooklyn, NY. In addition to his clinical training, Dr. Weltz has spent considerable time conducting hematology-oncology research and presenting at national conferences, including the American Society of Hematology. He finds it particularly gratifying when he can contribute to research that has a direct impact on treatment for cancer patients and has authored publications in Blood, Nature, Journal of Clinical Oncology as well as Expert Review of Hematology. He is a fellow of the American College of Physicians and a member of the American Society of Hematology, American Society of Clinical Oncology and American Osteopathic Association.Dr. Weltz is passionate about hematology-oncology and is grateful to play a pivotal role with patients throughout the course of their treatment. His approach to patient care is based on joint decision-making, believes in working closely with his patients while providing them with the latest information and data they need to make active, informed decisions in line with their life goals. In his free time, Dr. Weltz is devoted to spending time with his wife and two daughters and enjoys outdoor activities such as running, biking and hiking.

Matthen Mathew, M.D., is a board-certified medical oncologist at the Eugene M. & Christine E. Lynn Cancer Institute, part of Baptist Health, at Boca Raton Regional Hospital, with expertise in lung cancer, head and neck cancer, and benign hematology. Before joining Baptist Health, Dr. Mathew was an assistant professor of medicine in the Division of Hematology-Oncology, Vagelos College of Physicians and Surgeons at Columbia University. Dr. Mathew earned his medical degree at University of Florida College of Medicine. He completed his internal medicine residency at the Icahn School of Medicine at Mount Sinai, where he was selected to be chief resident. He then completed fellowship training in hematology and medical oncology at New York Presbyterian Hospital/ColumbiaUniversity Medical Center, where he was appointed chief fellow. In addition to his clinical expertise, Dr. Mathew has extensive experience in clinical trials research and immuno-oncology. He has been the site principal investigator for large, national cooperative group studies and has also designed and implemented trials focused on advancing new and more effective treatments for patients. He is a member of the American Society of Clinical Oncology and the American Board of Internal Medicine. Dr. Mathew believes a multidisciplinary approach to treatment is crucial for cancer care. His approach to patient care involves working together with the rest of the cancer care team — from surgeons to social workers — to ensure that patients have a strong support network during treatment. In his free time, Dr. Mathew enjoys spending time with his wife and three sons. His favorite activities include going to the beach, playing tennis and golfing.

Zdenka Ena Segota, M.D., is a board-certified hematologist oncologist with the Eugene M. & Christine E. Lynn Cancer Institute, part of Baptist Health, at Boca Raton Regional Hospital. Her clinical interests include breast cancer and hematologic malignancies such as lymphoma and myeloma. Dr. Segota has extensive research experience, putting her at the forefront of innovations in cancer care. During her career, she has served as principal investigator or sub-investigator on numerous clinical trials that have resulted in the development of many new oncology medications. These studies aim to improve patients’ pre-surgical and post-surgical outcomes as well as metastatic cancer survival rates. Dr. Segota earned her medical degree at the University of Zagreb, School of Medicine in Croatia. She completed an internal medicine internship and residency at Cleveland Clinic Health System, Huron Hospital. Her extensive training also includes a hematology and medical oncology fellowship and experimental therapeutics research fellowship at Cleveland Clinic Cancer Center, Taussig Cancer Institute. Dr. Segota enjoys connecting and interacting with her patients and believes that every person deserves to receive an individual approach to cancer care. She offers patients precision medicine through genomic testing. This type of testing identifies disease-associated variants to help match patients to more personalized therapies or assess a patient’s disease risk and help target more effective therapies. Dr. Segota speaks English and Croatian. In her free time, she enjoys traveling, gardening, renovating houses and spending time with her family.